ArticleMolecular cancer therapeutics2020

CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma.

Guillermo Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.